Anika Therapeutics, Inc. - ANIK

All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)? Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).

Files summary

Total files loaded: 17
Latest filed: Aug 07, 2026
Form Count
4 9
8-K 4
SCHEDULE 13G/A 2
144 1
SCHEDULE 13G 1

Latest files

Filed Form Report period Accession SEC
Aug 07, 2026 144 — 0001959173-26-005793 View
Aug 05, 2026 4 Aug 03, 2026 0001193125-26-335269 View
Jul 31, 2026 SCHEDULE 13G/A — 0002100119-26-001342 View
Jul 29, 2026 8-K Jul 29, 2026 0001171843-26-004977 View
Jul 17, 2026 SCHEDULE 13G/A — 0002052113-26-000740 View
Jul 14, 2026 8-K Jul 10, 2026 0001171843-26-004635 View
Jun 23, 2026 8-K Jun 18, 2026 0001171843-26-004253 View
Jun 23, 2026 4 Jun 18, 2026 0001193125-26-279535 View
Jun 23, 2026 4 Jun 18, 2026 0001193125-26-279539 View
Jun 23, 2026 4 Jun 18, 2026 0001193125-26-279541 View
Jun 23, 2026 4 Jun 18, 2026 0001193125-26-279542 View
Jun 23, 2026 4 Jun 18, 2026 0001193125-26-279545 View
Jun 05, 2026 4 Jun 03, 2026 0001193125-26-259520 View
May 04, 2026 4 May 01, 2026 0001193125-26-202704 View
Apr 30, 2026 4 Apr 30, 2026 0001193125-26-197887 View
Apr 29, 2026 SCHEDULE 13G — 0002100119-26-000113 View
Apr 29, 2026 8-K Apr 24, 2026 0001171843-26-002799 View